Earlier this year, Rachel Cawley joined UPMC Enterprises as a Business Analyst. She now helps evaluate PHDA proposals, track the progress of each team’s research, and assist with any challenges that may arise. Rachel works closely with both teams at CMU and Pitt to continually identify synergies between PHDA research and commercial opportunities for this research. We’re so grateful for Rachel’s work on behalf of the PHDA and look forward to her continued support in the coming year.
Additionally, the COVID-19 pandemic spurred rapid changes across healthcare, initiated the adoption of new digital health tools and services, and inspired new lines of research to understand and fight the coronavirus. Despite the many challenges that the pandemic created for our researchers, they persevered and continued to demonstrate progress and success in their respective areas.
We kicked off several new projects in 2020 and had a few of our teams publish exciting results throughout the year that we featured in more than 25 blog posts highlighting the awesome work taking place by the PHDA. Stop by our blog to browse around and learn more about us.
Later in the year, we announced initial results from our collaboration with Amazon Web Services (AWS) – advancing innovation in areas such as cancer diagnostics, precision medicine, electronic health records, and medical imaging. This work is fueled by new advances in machine learning technologies and enhanced access to computing power, which have offered new opportunities for researchers and healthcare professionals to understand and treat some of the most prolific diseases.
All in all, 2020 was certainly a year to remember and we look forward to what 2021 has in store. As always, we will support new investigations led by collaborative, interdisciplinary teams and work with current teams as they take the next steps in the development and commercialization of their innovative solutions. On behalf of the PHDA, thanks for your support!